Atlas Trials

A Study of RC48-ADC in Subjects With Advanced Breast Cancer

Clinical trial NCT03052634 · COMPLETED

Trial details

NCT number
NCT03052634
Sponsor
RemeGen Co., Ltd.
Status
COMPLETED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Advanced Breast Cancer
Start date
2016-12-23
Primary completion
2022-07-31
Enrollment
112

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.